The pandemic has significantly impacted the market studied. The number of visits to hospitals and clinics for medical and cosmetic purposes decreased, leading to a decrease in the demand for minimally invasive devices. In the United Kingdom, device manufacturers recorded a significant decrease in their revenue compared to growth rates in the past decade. Companies are taking significant measures to combat the impact of COVID-19. In February 2021, an article published in the BMJ journal stated that NHS England show that the number of patients awaiting treatment hit a record high of 4.46 million in the past year. Thus, initial restrictions adversely impacted the market growth. However, with the ease of lockdowns, the pending surgeries have started to undergo which is expected to increase the demand for minimally invasive surgeries in the country thus increasing market growth.
The major factors for the growth of the market include the increasing prevalence of lifestyle-related and chronic disorders, along with the rising geriatric population in the country and technological advancements. The growing burden of chronic diseases, along with the increasing technological advancements in the United Kingdom, is likely to lead to increased demand for minimally invasive surgery devices. As per the “British Association of Aesthetic Plastic Surgeons (BAAPS)” report released in February 2021, approximately 15 thousand cosmetic surgeries were carried out in the United Kingdom in 2021. According to the same source, breast augmentation was the most popular cosmetic surgery among women in the country in the past year, with over 4.6 thousand treatments, followed by breast reduction with over 3.1 thousand procedures. In addition, with 413 operations performed in the past year, rhinoplasty was the most popular surgery among men in the same year. Such instances imply greater demand for minimally invasive surgeries in the country, bolstering the market's growth. Thus, owing to the above-mentioned factors, the demand for minimally invasive surgical devices is expected to increase during the forecast period.
However, the shortage of experienced professionals is expected to hinder market growth.
UK Minimally Invasive Surgery Devices Market Trends
Cardiovascular Segment is Expected to Hold a Significant Market Share Over the Forecast Period
The major factor driving the growth of the segment is the rising incidence of gastrointestinal diseases in the young, adult, and geriatric groups. Increasing obesity is expected to increase the burden of cardiac diseases in the country. The UK Factsheet report of the British Heart Foundation, which was released in July 2021, estimated that 7.6 million people in the United Kingdom were affected by heart and circulation disorders. According to the same source, heart and circulation disorders in the United Kingdom accounted for more than 160,000 deaths annually or 25% of all fatalities in the country. As a result, there is a growing demand for cardiac surgery in the country due to the high prevalence of heart disorders. Government assistance in the form of grants is promoting industry expansion over time. For instance, the development of the CUOREMA project by the United Kingdom-based health technology business MyHealth and its partners received a EUR 2.5 million Eurostars Grant in May 2021. The creation of a novel, patient-centered cardiac rehabilitation support system is the main goal of the CUOREMA project. Thus, such initiatives are expected to increase the market's growth.Robotic Assisted Surgical Systems are Expected to See Significant Growth Over the Forecast Period
Factors such as the increasing prevalence of chronic diseases and initiatives by key market players are expected to boost market growth over the forecast period. There is a large number of people affected by musculoskeletal diseases in the country. For instance, as per the report published by Versus Arthritis in November 2021, over 20.3 million people in the United Kingdom were affected by musculoskeletal (MSK) conditions, such as arthritis or back pain. The disease prevalence by region is England: 17.1 million people (32%), Scotland: 1.7 million people (33%), Wales: 974,000 people (29%), and Northern Ireland: 525,000 people (29%). Thus, the increasing prevalence of such chronic disorders is expected to increase segmental growth.Initiatives by key market players in the country are another factor driving the market growth. For instance, in October 2022, the Royal College of Surgeons of England (RCS England) unveiled a da Vinci Si robotic-assisted surgical system in the college’s newly transformed headquarters for robotic-assisted surgeries.
Partnerships are another driver of market growth. For instance, in March 2022, CMR Surgical (CMR) - a global surgical robotics business, was awarded a significant multi-year contract by NHS Wales for the implementation of the Versius Surgical Robotic System in a National Robotics Assisted Surgery Programme. Under the contract terms, four Versius systems will initially be installed across several hospitals in Wales, with over 1,300 patients expected to benefit from the program annually. Thus, the increasing prevalence of chronic diseases, coupled with initiatives such as partnerships, is expected to increase the adoption of robotic-assisted surgeries, which is expected to boost segmental growth over the forecast period.
UK Minimally Invasive Surgery Devices Market Competitor Analysis
The UK market for minimally invasive surgery devices is moderately consolidated, owing to the presence of a few key players in the market. Some of the market players are Stryker Corporation, Medtronic PLC, Olympus Corporation, Abbott Laboratories, and Zimmer Biomet, among others.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic PLC
- Olympus Corporation
- Siemens Healthineers
- Koninklijke Philips NV
- GE Healthcare
- Abbott Laboratories
- Intuitive Surgical Inc.
- Smith & Nephew
- Stryker Corporation
- Zimmer Biomet
Methodology
LOADING...